Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04083014
Brief Title: Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia (RRAIHA01)

First Submitted : August 31, 2019
First Submitted that Met QC Criteria : September 5, 2019
First Posted : September 10, 2019

Last Update Submitted that Met QC Criteria : September 5, 2019
Last Update Posted : September 10, 2019